No abstract available
MeSH terms
-
Aged
-
Antimetabolites, Antineoplastic / adverse effects*
-
Antimetabolites, Antineoplastic / therapeutic use
-
Azacitidine / adverse effects*
-
Azacitidine / therapeutic use
-
Fatal Outcome
-
Humans
-
Male
-
Myelodysplastic Syndromes / complications*
-
Myelodysplastic Syndromes / drug therapy
-
Sweet Syndrome / diagnosis
-
Sweet Syndrome / drug therapy
-
Sweet Syndrome / etiology*
-
Sweet Syndrome / immunology
-
Vasculitis / diagnosis
-
Vasculitis / drug therapy
-
Vasculitis / etiology*
-
Vasculitis / immunology
Substances
-
Antimetabolites, Antineoplastic
-
Azacitidine